New biomarkers could improve diagnosis and tracking of Parkinson's disease and Lewy body dementia
Investigators led by Tanya Simuni, MD, the Arthur C. Nielsen, Jr., Research Professor of Parkinson's Disease and Movement ...
GlobalData on MSN22h
CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA ...
Woman's World on MSN1d
Doctors Explain How Dementia and Alzheimer’s Differ, Plus Signs To Watch For
Someone with FTD may also notice changes in personality or mood and difficulties with language. Dr. McGrath points out that ...
Wigan Today on MSN6d
Wigan charity celebrates five years of funding UK’s first Consultant Admiral Nurse for Lewy body dementia
Dementia charity Lewy Body Society is celebrating its five years of funding the UK’s first Consultant Admiral Nurse for Lewy ...
CervoMed gains as dementia therapy granted FDA orphan tag
CervoMed (CRVO) stock rises as FDA grants Orphan Drug Designation for neflamapimod to treat frontotemporal dementia. Read ...
Robbie Williams shares devastating family news
Robbie's mother Janet is battling with dementia, four years after he revealed his dad Pete has Parkinson's disease ...
TMCnet1d
CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders. On track to report topline data ...
Two U.S. Air Force veterans reunite in Summerville for first time in 60 years
William Hamilton and John Kelly, both 90 years old, served together in the Air Force and Wednesday night was the first time ...
Business Insider3d
Cognition announces all participants completed final visit in SHIMMER study
Cognition Therapeutics (CGTX) announced that the last patient has completed their final clinic visit in the Phase 2 SHIMMER study of CT1812 in patients with mild-to-moderate dementia with Lewy bodies, ...
Business Insider2d
CervoMed Says FDA Grants Orphan Drug Designation For Neflamapimod In Frontotemporal Dementia
The company is on track to report topline data from the RewinD-LB Phase 2b clinical trial in early-stage dementia with Lewy bodies (DLB) in December 2024. The company is continuing to prepare to ...